Global GLP-1 Weight Loss Drug Supply, Demand and Key Producers, 2023-2029
The global GLP-1 Weight Loss Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
GLP-1 (Glucagon-Like Peptide-1) weight loss drugs are a class of drugs used to treat obesity and control weight. GLP-1 is a naturally occurring insulin-releasing hormone produced by cells in the small intestine after food ingestion and has multiple physiological effects, including stimulating insulin secretion and inhibiting gastric emptying, thereby slowing the passage of food through the gastrointestinal tract. GLP-1 weight loss drugs simulate the biological activity of GLP-1 and trigger a series of physiological reactions, which help reduce appetite, increase satiety, and reduce calorie intake, thereby helping people lose weight. This class of drugs is often used to treat obesity, especially in obese patients who are at risk for diabetes.
This report studies the global GLP-1 Weight Loss Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for GLP-1 Weight Loss Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of GLP-1 Weight Loss Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global GLP-1 Weight Loss Drug total production and demand, 2018-2029, (K Units)
Global GLP-1 Weight Loss Drug total production value, 2018-2029, (USD Million)
Global GLP-1 Weight Loss Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global GLP-1 Weight Loss Drug consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: GLP-1 Weight Loss Drug domestic production, consumption, key domestic manufacturers and share
Global GLP-1 Weight Loss Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global GLP-1 Weight Loss Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global GLP-1 Weight Loss Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global GLP-1 Weight Loss Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, AstraZeneca, Eli Lilly, Sanofi, BENEMAE, HANSOH PHARMLA, CHIATAI TIANQING, Tonghua Dongbao Pharmaceutical and Huadong Medicine, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World GLP-1 Weight Loss Drug market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global GLP-1 Weight Loss Drug Market, By Region:
1. How big is the global GLP-1 Weight Loss Drug market?
2. What is the demand of the global GLP-1 Weight Loss Drug market?
3. What is the year over year growth of the global GLP-1 Weight Loss Drug market?
4. What is the production and production value of the global GLP-1 Weight Loss Drug market?
5. Who are the key producers in the global GLP-1 Weight Loss Drug market?
GLP-1 (Glucagon-Like Peptide-1) weight loss drugs are a class of drugs used to treat obesity and control weight. GLP-1 is a naturally occurring insulin-releasing hormone produced by cells in the small intestine after food ingestion and has multiple physiological effects, including stimulating insulin secretion and inhibiting gastric emptying, thereby slowing the passage of food through the gastrointestinal tract. GLP-1 weight loss drugs simulate the biological activity of GLP-1 and trigger a series of physiological reactions, which help reduce appetite, increase satiety, and reduce calorie intake, thereby helping people lose weight. This class of drugs is often used to treat obesity, especially in obese patients who are at risk for diabetes.
This report studies the global GLP-1 Weight Loss Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for GLP-1 Weight Loss Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of GLP-1 Weight Loss Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global GLP-1 Weight Loss Drug total production and demand, 2018-2029, (K Units)
Global GLP-1 Weight Loss Drug total production value, 2018-2029, (USD Million)
Global GLP-1 Weight Loss Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global GLP-1 Weight Loss Drug consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: GLP-1 Weight Loss Drug domestic production, consumption, key domestic manufacturers and share
Global GLP-1 Weight Loss Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global GLP-1 Weight Loss Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global GLP-1 Weight Loss Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global GLP-1 Weight Loss Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, AstraZeneca, Eli Lilly, Sanofi, BENEMAE, HANSOH PHARMLA, CHIATAI TIANQING, Tonghua Dongbao Pharmaceutical and Huadong Medicine, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World GLP-1 Weight Loss Drug market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global GLP-1 Weight Loss Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Injection
- Oral
- Online Pharmacy
- Offline Pharmacy
- Novo Nordisk
- AstraZeneca
- Eli Lilly
- Sanofi
- BENEMAE
- HANSOH PHARMLA
- CHIATAI TIANQING
- Tonghua Dongbao Pharmaceutical
- Huadong Medicine
1. How big is the global GLP-1 Weight Loss Drug market?
2. What is the demand of the global GLP-1 Weight Loss Drug market?
3. What is the year over year growth of the global GLP-1 Weight Loss Drug market?
4. What is the production and production value of the global GLP-1 Weight Loss Drug market?
5. Who are the key producers in the global GLP-1 Weight Loss Drug market?
1 SUPPLY SUMMARY
1.1 GLP-1 Weight Loss Drug Introduction
1.2 World GLP-1 Weight Loss Drug Supply & Forecast
1.2.1 World GLP-1 Weight Loss Drug Production Value (2018 & 2022 & 2029)
1.2.2 World GLP-1 Weight Loss Drug Production (2018-2029)
1.2.3 World GLP-1 Weight Loss Drug Pricing Trends (2018-2029)
1.3 World GLP-1 Weight Loss Drug Production by Region (Based on Production Site)
1.3.1 World GLP-1 Weight Loss Drug Production Value by Region (2018-2029)
1.3.2 World GLP-1 Weight Loss Drug Production by Region (2018-2029)
1.3.3 World GLP-1 Weight Loss Drug Average Price by Region (2018-2029)
1.3.4 North America GLP-1 Weight Loss Drug Production (2018-2029)
1.3.5 Europe GLP-1 Weight Loss Drug Production (2018-2029)
1.3.6 China GLP-1 Weight Loss Drug Production (2018-2029)
1.3.7 Japan GLP-1 Weight Loss Drug Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 GLP-1 Weight Loss Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 GLP-1 Weight Loss Drug Major Market Trends
2 DEMAND SUMMARY
2.1 World GLP-1 Weight Loss Drug Demand (2018-2029)
2.2 World GLP-1 Weight Loss Drug Consumption by Region
2.2.1 World GLP-1 Weight Loss Drug Consumption by Region (2018-2023)
2.2.2 World GLP-1 Weight Loss Drug Consumption Forecast by Region (2024-2029)
2.3 United States GLP-1 Weight Loss Drug Consumption (2018-2029)
2.4 China GLP-1 Weight Loss Drug Consumption (2018-2029)
2.5 Europe GLP-1 Weight Loss Drug Consumption (2018-2029)
2.6 Japan GLP-1 Weight Loss Drug Consumption (2018-2029)
2.7 South Korea GLP-1 Weight Loss Drug Consumption (2018-2029)
2.8 ASEAN GLP-1 Weight Loss Drug Consumption (2018-2029)
2.9 India GLP-1 Weight Loss Drug Consumption (2018-2029)
3 WORLD GLP-1 WEIGHT LOSS DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World GLP-1 Weight Loss Drug Production Value by Manufacturer (2018-2023)
3.2 World GLP-1 Weight Loss Drug Production by Manufacturer (2018-2023)
3.3 World GLP-1 Weight Loss Drug Average Price by Manufacturer (2018-2023)
3.4 GLP-1 Weight Loss Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global GLP-1 Weight Loss Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for GLP-1 Weight Loss Drug in 2022
3.5.3 Global Concentration Ratios (CR8) for GLP-1 Weight Loss Drug in 2022
3.6 GLP-1 Weight Loss Drug Market: Overall Company Footprint Analysis
3.6.1 GLP-1 Weight Loss Drug Market: Region Footprint
3.6.2 GLP-1 Weight Loss Drug Market: Company Product Type Footprint
3.6.3 GLP-1 Weight Loss Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: GLP-1 Weight Loss Drug Production Value Comparison
4.1.1 United States VS China: GLP-1 Weight Loss Drug Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: GLP-1 Weight Loss Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: GLP-1 Weight Loss Drug Production Comparison
4.2.1 United States VS China: GLP-1 Weight Loss Drug Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: GLP-1 Weight Loss Drug Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: GLP-1 Weight Loss Drug Consumption Comparison
4.3.1 United States VS China: GLP-1 Weight Loss Drug Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: GLP-1 Weight Loss Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based GLP-1 Weight Loss Drug Manufacturers and Market Share, 2018-2023
4.4.1 United States Based GLP-1 Weight Loss Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers GLP-1 Weight Loss Drug Production Value (2018-2023)
4.4.3 United States Based Manufacturers GLP-1 Weight Loss Drug Production (2018-2023)
4.5 China Based GLP-1 Weight Loss Drug Manufacturers and Market Share
4.5.1 China Based GLP-1 Weight Loss Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers GLP-1 Weight Loss Drug Production Value (2018-2023)
4.5.3 China Based Manufacturers GLP-1 Weight Loss Drug Production (2018-2023)
4.6 Rest of World Based GLP-1 Weight Loss Drug Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based GLP-1 Weight Loss Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers GLP-1 Weight Loss Drug Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers GLP-1 Weight Loss Drug Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World GLP-1 Weight Loss Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Injection
5.2.2 Oral
5.3 Market Segment by Type
5.3.1 World GLP-1 Weight Loss Drug Production by Type (2018-2029)
5.3.2 World GLP-1 Weight Loss Drug Production Value by Type (2018-2029)
5.3.3 World GLP-1 Weight Loss Drug Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World GLP-1 Weight Loss Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Online Pharmacy
6.2.2 Offline Pharmacy
6.3 Market Segment by Application
6.3.1 World GLP-1 Weight Loss Drug Production by Application (2018-2029)
6.3.2 World GLP-1 Weight Loss Drug Production Value by Application (2018-2029)
6.3.3 World GLP-1 Weight Loss Drug Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Novo Nordisk
7.1.1 Novo Nordisk Details
7.1.2 Novo Nordisk Major Business
7.1.3 Novo Nordisk GLP-1 Weight Loss Drug Product and Services
7.1.4 Novo Nordisk GLP-1 Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Novo Nordisk Recent Developments/Updates
7.1.6 Novo Nordisk Competitive Strengths & Weaknesses
7.2 AstraZeneca
7.2.1 AstraZeneca Details
7.2.2 AstraZeneca Major Business
7.2.3 AstraZeneca GLP-1 Weight Loss Drug Product and Services
7.2.4 AstraZeneca GLP-1 Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 AstraZeneca Recent Developments/Updates
7.2.6 AstraZeneca Competitive Strengths & Weaknesses
7.3 Eli Lilly
7.3.1 Eli Lilly Details
7.3.2 Eli Lilly Major Business
7.3.3 Eli Lilly GLP-1 Weight Loss Drug Product and Services
7.3.4 Eli Lilly GLP-1 Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Eli Lilly Recent Developments/Updates
7.3.6 Eli Lilly Competitive Strengths & Weaknesses
7.4 Sanofi
7.4.1 Sanofi Details
7.4.2 Sanofi Major Business
7.4.3 Sanofi GLP-1 Weight Loss Drug Product and Services
7.4.4 Sanofi GLP-1 Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Sanofi Recent Developments/Updates
7.4.6 Sanofi Competitive Strengths & Weaknesses
7.5 BENEMAE
7.5.1 BENEMAE Details
7.5.2 BENEMAE Major Business
7.5.3 BENEMAE GLP-1 Weight Loss Drug Product and Services
7.5.4 BENEMAE GLP-1 Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 BENEMAE Recent Developments/Updates
7.5.6 BENEMAE Competitive Strengths & Weaknesses
7.6 HANSOH PHARMLA
7.6.1 HANSOH PHARMLA Details
7.6.2 HANSOH PHARMLA Major Business
7.6.3 HANSOH PHARMLA GLP-1 Weight Loss Drug Product and Services
7.6.4 HANSOH PHARMLA GLP-1 Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 HANSOH PHARMLA Recent Developments/Updates
7.6.6 HANSOH PHARMLA Competitive Strengths & Weaknesses
7.7 CHIATAI TIANQING
7.7.1 CHIATAI TIANQING Details
7.7.2 CHIATAI TIANQING Major Business
7.7.3 CHIATAI TIANQING GLP-1 Weight Loss Drug Product and Services
7.7.4 CHIATAI TIANQING GLP-1 Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 CHIATAI TIANQING Recent Developments/Updates
7.7.6 CHIATAI TIANQING Competitive Strengths & Weaknesses
7.8 Tonghua Dongbao Pharmaceutical
7.8.1 Tonghua Dongbao Pharmaceutical Details
7.8.2 Tonghua Dongbao Pharmaceutical Major Business
7.8.3 Tonghua Dongbao Pharmaceutical GLP-1 Weight Loss Drug Product and Services
7.8.4 Tonghua Dongbao Pharmaceutical GLP-1 Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Tonghua Dongbao Pharmaceutical Recent Developments/Updates
7.8.6 Tonghua Dongbao Pharmaceutical Competitive Strengths & Weaknesses
7.9 Huadong Medicine
7.9.1 Huadong Medicine Details
7.9.2 Huadong Medicine Major Business
7.9.3 Huadong Medicine GLP-1 Weight Loss Drug Product and Services
7.9.4 Huadong Medicine GLP-1 Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Huadong Medicine Recent Developments/Updates
7.9.6 Huadong Medicine Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 GLP-1 Weight Loss Drug Industry Chain
8.2 GLP-1 Weight Loss Drug Upstream Analysis
8.2.1 GLP-1 Weight Loss Drug Core Raw Materials
8.2.2 Main Manufacturers of GLP-1 Weight Loss Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 GLP-1 Weight Loss Drug Production Mode
8.6 GLP-1 Weight Loss Drug Procurement Model
8.7 GLP-1 Weight Loss Drug Industry Sales Model and Sales Channels
8.7.1 GLP-1 Weight Loss Drug Sales Model
8.7.2 GLP-1 Weight Loss Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 GLP-1 Weight Loss Drug Introduction
1.2 World GLP-1 Weight Loss Drug Supply & Forecast
1.2.1 World GLP-1 Weight Loss Drug Production Value (2018 & 2022 & 2029)
1.2.2 World GLP-1 Weight Loss Drug Production (2018-2029)
1.2.3 World GLP-1 Weight Loss Drug Pricing Trends (2018-2029)
1.3 World GLP-1 Weight Loss Drug Production by Region (Based on Production Site)
1.3.1 World GLP-1 Weight Loss Drug Production Value by Region (2018-2029)
1.3.2 World GLP-1 Weight Loss Drug Production by Region (2018-2029)
1.3.3 World GLP-1 Weight Loss Drug Average Price by Region (2018-2029)
1.3.4 North America GLP-1 Weight Loss Drug Production (2018-2029)
1.3.5 Europe GLP-1 Weight Loss Drug Production (2018-2029)
1.3.6 China GLP-1 Weight Loss Drug Production (2018-2029)
1.3.7 Japan GLP-1 Weight Loss Drug Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 GLP-1 Weight Loss Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 GLP-1 Weight Loss Drug Major Market Trends
2 DEMAND SUMMARY
2.1 World GLP-1 Weight Loss Drug Demand (2018-2029)
2.2 World GLP-1 Weight Loss Drug Consumption by Region
2.2.1 World GLP-1 Weight Loss Drug Consumption by Region (2018-2023)
2.2.2 World GLP-1 Weight Loss Drug Consumption Forecast by Region (2024-2029)
2.3 United States GLP-1 Weight Loss Drug Consumption (2018-2029)
2.4 China GLP-1 Weight Loss Drug Consumption (2018-2029)
2.5 Europe GLP-1 Weight Loss Drug Consumption (2018-2029)
2.6 Japan GLP-1 Weight Loss Drug Consumption (2018-2029)
2.7 South Korea GLP-1 Weight Loss Drug Consumption (2018-2029)
2.8 ASEAN GLP-1 Weight Loss Drug Consumption (2018-2029)
2.9 India GLP-1 Weight Loss Drug Consumption (2018-2029)
3 WORLD GLP-1 WEIGHT LOSS DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World GLP-1 Weight Loss Drug Production Value by Manufacturer (2018-2023)
3.2 World GLP-1 Weight Loss Drug Production by Manufacturer (2018-2023)
3.3 World GLP-1 Weight Loss Drug Average Price by Manufacturer (2018-2023)
3.4 GLP-1 Weight Loss Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global GLP-1 Weight Loss Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for GLP-1 Weight Loss Drug in 2022
3.5.3 Global Concentration Ratios (CR8) for GLP-1 Weight Loss Drug in 2022
3.6 GLP-1 Weight Loss Drug Market: Overall Company Footprint Analysis
3.6.1 GLP-1 Weight Loss Drug Market: Region Footprint
3.6.2 GLP-1 Weight Loss Drug Market: Company Product Type Footprint
3.6.3 GLP-1 Weight Loss Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: GLP-1 Weight Loss Drug Production Value Comparison
4.1.1 United States VS China: GLP-1 Weight Loss Drug Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: GLP-1 Weight Loss Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: GLP-1 Weight Loss Drug Production Comparison
4.2.1 United States VS China: GLP-1 Weight Loss Drug Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: GLP-1 Weight Loss Drug Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: GLP-1 Weight Loss Drug Consumption Comparison
4.3.1 United States VS China: GLP-1 Weight Loss Drug Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: GLP-1 Weight Loss Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based GLP-1 Weight Loss Drug Manufacturers and Market Share, 2018-2023
4.4.1 United States Based GLP-1 Weight Loss Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers GLP-1 Weight Loss Drug Production Value (2018-2023)
4.4.3 United States Based Manufacturers GLP-1 Weight Loss Drug Production (2018-2023)
4.5 China Based GLP-1 Weight Loss Drug Manufacturers and Market Share
4.5.1 China Based GLP-1 Weight Loss Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers GLP-1 Weight Loss Drug Production Value (2018-2023)
4.5.3 China Based Manufacturers GLP-1 Weight Loss Drug Production (2018-2023)
4.6 Rest of World Based GLP-1 Weight Loss Drug Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based GLP-1 Weight Loss Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers GLP-1 Weight Loss Drug Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers GLP-1 Weight Loss Drug Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World GLP-1 Weight Loss Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Injection
5.2.2 Oral
5.3 Market Segment by Type
5.3.1 World GLP-1 Weight Loss Drug Production by Type (2018-2029)
5.3.2 World GLP-1 Weight Loss Drug Production Value by Type (2018-2029)
5.3.3 World GLP-1 Weight Loss Drug Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World GLP-1 Weight Loss Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Online Pharmacy
6.2.2 Offline Pharmacy
6.3 Market Segment by Application
6.3.1 World GLP-1 Weight Loss Drug Production by Application (2018-2029)
6.3.2 World GLP-1 Weight Loss Drug Production Value by Application (2018-2029)
6.3.3 World GLP-1 Weight Loss Drug Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Novo Nordisk
7.1.1 Novo Nordisk Details
7.1.2 Novo Nordisk Major Business
7.1.3 Novo Nordisk GLP-1 Weight Loss Drug Product and Services
7.1.4 Novo Nordisk GLP-1 Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Novo Nordisk Recent Developments/Updates
7.1.6 Novo Nordisk Competitive Strengths & Weaknesses
7.2 AstraZeneca
7.2.1 AstraZeneca Details
7.2.2 AstraZeneca Major Business
7.2.3 AstraZeneca GLP-1 Weight Loss Drug Product and Services
7.2.4 AstraZeneca GLP-1 Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 AstraZeneca Recent Developments/Updates
7.2.6 AstraZeneca Competitive Strengths & Weaknesses
7.3 Eli Lilly
7.3.1 Eli Lilly Details
7.3.2 Eli Lilly Major Business
7.3.3 Eli Lilly GLP-1 Weight Loss Drug Product and Services
7.3.4 Eli Lilly GLP-1 Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Eli Lilly Recent Developments/Updates
7.3.6 Eli Lilly Competitive Strengths & Weaknesses
7.4 Sanofi
7.4.1 Sanofi Details
7.4.2 Sanofi Major Business
7.4.3 Sanofi GLP-1 Weight Loss Drug Product and Services
7.4.4 Sanofi GLP-1 Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Sanofi Recent Developments/Updates
7.4.6 Sanofi Competitive Strengths & Weaknesses
7.5 BENEMAE
7.5.1 BENEMAE Details
7.5.2 BENEMAE Major Business
7.5.3 BENEMAE GLP-1 Weight Loss Drug Product and Services
7.5.4 BENEMAE GLP-1 Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 BENEMAE Recent Developments/Updates
7.5.6 BENEMAE Competitive Strengths & Weaknesses
7.6 HANSOH PHARMLA
7.6.1 HANSOH PHARMLA Details
7.6.2 HANSOH PHARMLA Major Business
7.6.3 HANSOH PHARMLA GLP-1 Weight Loss Drug Product and Services
7.6.4 HANSOH PHARMLA GLP-1 Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 HANSOH PHARMLA Recent Developments/Updates
7.6.6 HANSOH PHARMLA Competitive Strengths & Weaknesses
7.7 CHIATAI TIANQING
7.7.1 CHIATAI TIANQING Details
7.7.2 CHIATAI TIANQING Major Business
7.7.3 CHIATAI TIANQING GLP-1 Weight Loss Drug Product and Services
7.7.4 CHIATAI TIANQING GLP-1 Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 CHIATAI TIANQING Recent Developments/Updates
7.7.6 CHIATAI TIANQING Competitive Strengths & Weaknesses
7.8 Tonghua Dongbao Pharmaceutical
7.8.1 Tonghua Dongbao Pharmaceutical Details
7.8.2 Tonghua Dongbao Pharmaceutical Major Business
7.8.3 Tonghua Dongbao Pharmaceutical GLP-1 Weight Loss Drug Product and Services
7.8.4 Tonghua Dongbao Pharmaceutical GLP-1 Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Tonghua Dongbao Pharmaceutical Recent Developments/Updates
7.8.6 Tonghua Dongbao Pharmaceutical Competitive Strengths & Weaknesses
7.9 Huadong Medicine
7.9.1 Huadong Medicine Details
7.9.2 Huadong Medicine Major Business
7.9.3 Huadong Medicine GLP-1 Weight Loss Drug Product and Services
7.9.4 Huadong Medicine GLP-1 Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Huadong Medicine Recent Developments/Updates
7.9.6 Huadong Medicine Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 GLP-1 Weight Loss Drug Industry Chain
8.2 GLP-1 Weight Loss Drug Upstream Analysis
8.2.1 GLP-1 Weight Loss Drug Core Raw Materials
8.2.2 Main Manufacturers of GLP-1 Weight Loss Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 GLP-1 Weight Loss Drug Production Mode
8.6 GLP-1 Weight Loss Drug Procurement Model
8.7 GLP-1 Weight Loss Drug Industry Sales Model and Sales Channels
8.7.1 GLP-1 Weight Loss Drug Sales Model
8.7.2 GLP-1 Weight Loss Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World GLP-1 Weight Loss Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World GLP-1 Weight Loss Drug Production Value by Region (2018-2023) & (USD Million)
Table 3. World GLP-1 Weight Loss Drug Production Value by Region (2024-2029) & (USD Million)
Table 4. World GLP-1 Weight Loss Drug Production Value Market Share by Region (2018-2023)
Table 5. World GLP-1 Weight Loss Drug Production Value Market Share by Region (2024-2029)
Table 6. World GLP-1 Weight Loss Drug Production by Region (2018-2023) & (K Units)
Table 7. World GLP-1 Weight Loss Drug Production by Region (2024-2029) & (K Units)
Table 8. World GLP-1 Weight Loss Drug Production Market Share by Region (2018-2023)
Table 9. World GLP-1 Weight Loss Drug Production Market Share by Region (2024-2029)
Table 10. World GLP-1 Weight Loss Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World GLP-1 Weight Loss Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 12. GLP-1 Weight Loss Drug Major Market Trends
Table 13. World GLP-1 Weight Loss Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World GLP-1 Weight Loss Drug Consumption by Region (2018-2023) & (K Units)
Table 15. World GLP-1 Weight Loss Drug Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World GLP-1 Weight Loss Drug Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key GLP-1 Weight Loss Drug Producers in 2022
Table 18. World GLP-1 Weight Loss Drug Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key GLP-1 Weight Loss Drug Producers in 2022
Table 20. World GLP-1 Weight Loss Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global GLP-1 Weight Loss Drug Company Evaluation Quadrant
Table 22. World GLP-1 Weight Loss Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and GLP-1 Weight Loss Drug Production Site of Key Manufacturer
Table 24. GLP-1 Weight Loss Drug Market: Company Product Type Footprint
Table 25. GLP-1 Weight Loss Drug Market: Company Product Application Footprint
Table 26. GLP-1 Weight Loss Drug Competitive Factors
Table 27. GLP-1 Weight Loss Drug New Entrant and Capacity Expansion Plans
Table 28. GLP-1 Weight Loss Drug Mergers & Acquisitions Activity
Table 29. United States VS China GLP-1 Weight Loss Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China GLP-1 Weight Loss Drug Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China GLP-1 Weight Loss Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based GLP-1 Weight Loss Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers GLP-1 Weight Loss Drug Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers GLP-1 Weight Loss Drug Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers GLP-1 Weight Loss Drug Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers GLP-1 Weight Loss Drug Production Market Share (2018-2023)
Table 37. China Based GLP-1 Weight Loss Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers GLP-1 Weight Loss Drug Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers GLP-1 Weight Loss Drug Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers GLP-1 Weight Loss Drug Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers GLP-1 Weight Loss Drug Production Market Share (2018-2023)
Table 42. Rest of World Based GLP-1 Weight Loss Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers GLP-1 Weight Loss Drug Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers GLP-1 Weight Loss Drug Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers GLP-1 Weight Loss Drug Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers GLP-1 Weight Loss Drug Production Market Share (2018-2023)
Table 47. World GLP-1 Weight Loss Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World GLP-1 Weight Loss Drug Production by Type (2018-2023) & (K Units)
Table 49. World GLP-1 Weight Loss Drug Production by Type (2024-2029) & (K Units)
Table 50. World GLP-1 Weight Loss Drug Production Value by Type (2018-2023) & (USD Million)
Table 51. World GLP-1 Weight Loss Drug Production Value by Type (2024-2029) & (USD Million)
Table 52. World GLP-1 Weight Loss Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World GLP-1 Weight Loss Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World GLP-1 Weight Loss Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World GLP-1 Weight Loss Drug Production by Application (2018-2023) & (K Units)
Table 56. World GLP-1 Weight Loss Drug Production by Application (2024-2029) & (K Units)
Table 57. World GLP-1 Weight Loss Drug Production Value by Application (2018-2023) & (USD Million)
Table 58. World GLP-1 Weight Loss Drug Production Value by Application (2024-2029) & (USD Million)
Table 59. World GLP-1 Weight Loss Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World GLP-1 Weight Loss Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 62. Novo Nordisk Major Business
Table 63. Novo Nordisk GLP-1 Weight Loss Drug Product and Services
Table 64. Novo Nordisk GLP-1 Weight Loss Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Novo Nordisk Recent Developments/Updates
Table 66. Novo Nordisk Competitive Strengths & Weaknesses
Table 67. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 68. AstraZeneca Major Business
Table 69. AstraZeneca GLP-1 Weight Loss Drug Product and Services
Table 70. AstraZeneca GLP-1 Weight Loss Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. AstraZeneca Recent Developments/Updates
Table 72. AstraZeneca Competitive Strengths & Weaknesses
Table 73. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 74. Eli Lilly Major Business
Table 75. Eli Lilly GLP-1 Weight Loss Drug Product and Services
Table 76. Eli Lilly GLP-1 Weight Loss Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Eli Lilly Recent Developments/Updates
Table 78. Eli Lilly Competitive Strengths & Weaknesses
Table 79. Sanofi Basic Information, Manufacturing Base and Competitors
Table 80. Sanofi Major Business
Table 81. Sanofi GLP-1 Weight Loss Drug Product and Services
Table 82. Sanofi GLP-1 Weight Loss Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Sanofi Recent Developments/Updates
Table 84. Sanofi Competitive Strengths & Weaknesses
Table 85. BENEMAE Basic Information, Manufacturing Base and Competitors
Table 86. BENEMAE Major Business
Table 87. BENEMAE GLP-1 Weight Loss Drug Product and Services
Table 88. BENEMAE GLP-1 Weight Loss Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. BENEMAE Recent Developments/Updates
Table 90. BENEMAE Competitive Strengths & Weaknesses
Table 91. HANSOH PHARMLA Basic Information, Manufacturing Base and Competitors
Table 92. HANSOH PHARMLA Major Business
Table 93. HANSOH PHARMLA GLP-1 Weight Loss Drug Product and Services
Table 94. HANSOH PHARMLA GLP-1 Weight Loss Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. HANSOH PHARMLA Recent Developments/Updates
Table 96. HANSOH PHARMLA Competitive Strengths & Weaknesses
Table 97. CHIATAI TIANQING Basic Information, Manufacturing Base and Competitors
Table 98. CHIATAI TIANQING Major Business
Table 99. CHIATAI TIANQING GLP-1 Weight Loss Drug Product and Services
Table 100. CHIATAI TIANQING GLP-1 Weight Loss Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. CHIATAI TIANQING Recent Developments/Updates
Table 102. CHIATAI TIANQING Competitive Strengths & Weaknesses
Table 103. Tonghua Dongbao Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 104. Tonghua Dongbao Pharmaceutical Major Business
Table 105. Tonghua Dongbao Pharmaceutical GLP-1 Weight Loss Drug Product and Services
Table 106. Tonghua Dongbao Pharmaceutical GLP-1 Weight Loss Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Tonghua Dongbao Pharmaceutical Recent Developments/Updates
Table 108. Huadong Medicine Basic Information, Manufacturing Base and Competitors
Table 109. Huadong Medicine Major Business
Table 110. Huadong Medicine GLP-1 Weight Loss Drug Product and Services
Table 111. Huadong Medicine GLP-1 Weight Loss Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 112. Global Key Players of GLP-1 Weight Loss Drug Upstream (Raw Materials)
Table 113. GLP-1 Weight Loss Drug Typical Customers
Table 114. GLP-1 Weight Loss Drug Typical Distributors
LIST OF FIGURE
Figure 1. GLP-1 Weight Loss Drug Picture
Figure 2. World GLP-1 Weight Loss Drug Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World GLP-1 Weight Loss Drug Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World GLP-1 Weight Loss Drug Production (2018-2029) & (K Units)
Figure 5. World GLP-1 Weight Loss Drug Average Price (2018-2029) & (US$/Unit)
Figure 6. World GLP-1 Weight Loss Drug Production Value Market Share by Region (2018-2029)
Figure 7. World GLP-1 Weight Loss Drug Production Market Share by Region (2018-2029)
Figure 8. North America GLP-1 Weight Loss Drug Production (2018-2029) & (K Units)
Figure 9. Europe GLP-1 Weight Loss Drug Production (2018-2029) & (K Units)
Figure 10. China GLP-1 Weight Loss Drug Production (2018-2029) & (K Units)
Figure 11. Japan GLP-1 Weight Loss Drug Production (2018-2029) & (K Units)
Figure 12. GLP-1 Weight Loss Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World GLP-1 Weight Loss Drug Consumption (2018-2029) & (K Units)
Figure 15. World GLP-1 Weight Loss Drug Consumption Market Share by Region (2018-2029)
Figure 16. United States GLP-1 Weight Loss Drug Consumption (2018-2029) & (K Units)
Figure 17. China GLP-1 Weight Loss Drug Consumption (2018-2029) & (K Units)
Figure 18. Europe GLP-1 Weight Loss Drug Consumption (2018-2029) & (K Units)
Figure 19. Japan GLP-1 Weight Loss Drug Consumption (2018-2029) & (K Units)
Figure 20. South Korea GLP-1 Weight Loss Drug Consumption (2018-2029) & (K Units)
Figure 21. ASEAN GLP-1 Weight Loss Drug Consumption (2018-2029) & (K Units)
Figure 22. India GLP-1 Weight Loss Drug Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of GLP-1 Weight Loss Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for GLP-1 Weight Loss Drug Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for GLP-1 Weight Loss Drug Markets in 2022
Figure 26. United States VS China: GLP-1 Weight Loss Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: GLP-1 Weight Loss Drug Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: GLP-1 Weight Loss Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers GLP-1 Weight Loss Drug Production Market Share 2022
Figure 30. China Based Manufacturers GLP-1 Weight Loss Drug Production Market Share 2022
Figure 31. Rest of World Based Manufacturers GLP-1 Weight Loss Drug Production Market Share 2022
Figure 32. World GLP-1 Weight Loss Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World GLP-1 Weight Loss Drug Production Value Market Share by Type in 2022
Figure 34. Injection
Figure 35. Oral
Figure 36. World GLP-1 Weight Loss Drug Production Market Share by Type (2018-2029)
Figure 37. World GLP-1 Weight Loss Drug Production Value Market Share by Type (2018-2029)
Figure 38. World GLP-1 Weight Loss Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World GLP-1 Weight Loss Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World GLP-1 Weight Loss Drug Production Value Market Share by Application in 2022
Figure 41. Online Pharmacy
Figure 42. Offline Pharmacy
Figure 43. World GLP-1 Weight Loss Drug Production Market Share by Application (2018-2029)
Figure 44. World GLP-1 Weight Loss Drug Production Value Market Share by Application (2018-2029)
Figure 45. World GLP-1 Weight Loss Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. GLP-1 Weight Loss Drug Industry Chain
Figure 47. GLP-1 Weight Loss Drug Procurement Model
Figure 48. GLP-1 Weight Loss Drug Sales Model
Figure 49. GLP-1 Weight Loss Drug Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
Table 1. World GLP-1 Weight Loss Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World GLP-1 Weight Loss Drug Production Value by Region (2018-2023) & (USD Million)
Table 3. World GLP-1 Weight Loss Drug Production Value by Region (2024-2029) & (USD Million)
Table 4. World GLP-1 Weight Loss Drug Production Value Market Share by Region (2018-2023)
Table 5. World GLP-1 Weight Loss Drug Production Value Market Share by Region (2024-2029)
Table 6. World GLP-1 Weight Loss Drug Production by Region (2018-2023) & (K Units)
Table 7. World GLP-1 Weight Loss Drug Production by Region (2024-2029) & (K Units)
Table 8. World GLP-1 Weight Loss Drug Production Market Share by Region (2018-2023)
Table 9. World GLP-1 Weight Loss Drug Production Market Share by Region (2024-2029)
Table 10. World GLP-1 Weight Loss Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World GLP-1 Weight Loss Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 12. GLP-1 Weight Loss Drug Major Market Trends
Table 13. World GLP-1 Weight Loss Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World GLP-1 Weight Loss Drug Consumption by Region (2018-2023) & (K Units)
Table 15. World GLP-1 Weight Loss Drug Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World GLP-1 Weight Loss Drug Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key GLP-1 Weight Loss Drug Producers in 2022
Table 18. World GLP-1 Weight Loss Drug Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key GLP-1 Weight Loss Drug Producers in 2022
Table 20. World GLP-1 Weight Loss Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global GLP-1 Weight Loss Drug Company Evaluation Quadrant
Table 22. World GLP-1 Weight Loss Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and GLP-1 Weight Loss Drug Production Site of Key Manufacturer
Table 24. GLP-1 Weight Loss Drug Market: Company Product Type Footprint
Table 25. GLP-1 Weight Loss Drug Market: Company Product Application Footprint
Table 26. GLP-1 Weight Loss Drug Competitive Factors
Table 27. GLP-1 Weight Loss Drug New Entrant and Capacity Expansion Plans
Table 28. GLP-1 Weight Loss Drug Mergers & Acquisitions Activity
Table 29. United States VS China GLP-1 Weight Loss Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China GLP-1 Weight Loss Drug Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China GLP-1 Weight Loss Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based GLP-1 Weight Loss Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers GLP-1 Weight Loss Drug Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers GLP-1 Weight Loss Drug Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers GLP-1 Weight Loss Drug Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers GLP-1 Weight Loss Drug Production Market Share (2018-2023)
Table 37. China Based GLP-1 Weight Loss Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers GLP-1 Weight Loss Drug Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers GLP-1 Weight Loss Drug Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers GLP-1 Weight Loss Drug Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers GLP-1 Weight Loss Drug Production Market Share (2018-2023)
Table 42. Rest of World Based GLP-1 Weight Loss Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers GLP-1 Weight Loss Drug Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers GLP-1 Weight Loss Drug Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers GLP-1 Weight Loss Drug Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers GLP-1 Weight Loss Drug Production Market Share (2018-2023)
Table 47. World GLP-1 Weight Loss Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World GLP-1 Weight Loss Drug Production by Type (2018-2023) & (K Units)
Table 49. World GLP-1 Weight Loss Drug Production by Type (2024-2029) & (K Units)
Table 50. World GLP-1 Weight Loss Drug Production Value by Type (2018-2023) & (USD Million)
Table 51. World GLP-1 Weight Loss Drug Production Value by Type (2024-2029) & (USD Million)
Table 52. World GLP-1 Weight Loss Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World GLP-1 Weight Loss Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World GLP-1 Weight Loss Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World GLP-1 Weight Loss Drug Production by Application (2018-2023) & (K Units)
Table 56. World GLP-1 Weight Loss Drug Production by Application (2024-2029) & (K Units)
Table 57. World GLP-1 Weight Loss Drug Production Value by Application (2018-2023) & (USD Million)
Table 58. World GLP-1 Weight Loss Drug Production Value by Application (2024-2029) & (USD Million)
Table 59. World GLP-1 Weight Loss Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World GLP-1 Weight Loss Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 62. Novo Nordisk Major Business
Table 63. Novo Nordisk GLP-1 Weight Loss Drug Product and Services
Table 64. Novo Nordisk GLP-1 Weight Loss Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Novo Nordisk Recent Developments/Updates
Table 66. Novo Nordisk Competitive Strengths & Weaknesses
Table 67. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 68. AstraZeneca Major Business
Table 69. AstraZeneca GLP-1 Weight Loss Drug Product and Services
Table 70. AstraZeneca GLP-1 Weight Loss Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. AstraZeneca Recent Developments/Updates
Table 72. AstraZeneca Competitive Strengths & Weaknesses
Table 73. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 74. Eli Lilly Major Business
Table 75. Eli Lilly GLP-1 Weight Loss Drug Product and Services
Table 76. Eli Lilly GLP-1 Weight Loss Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Eli Lilly Recent Developments/Updates
Table 78. Eli Lilly Competitive Strengths & Weaknesses
Table 79. Sanofi Basic Information, Manufacturing Base and Competitors
Table 80. Sanofi Major Business
Table 81. Sanofi GLP-1 Weight Loss Drug Product and Services
Table 82. Sanofi GLP-1 Weight Loss Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Sanofi Recent Developments/Updates
Table 84. Sanofi Competitive Strengths & Weaknesses
Table 85. BENEMAE Basic Information, Manufacturing Base and Competitors
Table 86. BENEMAE Major Business
Table 87. BENEMAE GLP-1 Weight Loss Drug Product and Services
Table 88. BENEMAE GLP-1 Weight Loss Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. BENEMAE Recent Developments/Updates
Table 90. BENEMAE Competitive Strengths & Weaknesses
Table 91. HANSOH PHARMLA Basic Information, Manufacturing Base and Competitors
Table 92. HANSOH PHARMLA Major Business
Table 93. HANSOH PHARMLA GLP-1 Weight Loss Drug Product and Services
Table 94. HANSOH PHARMLA GLP-1 Weight Loss Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. HANSOH PHARMLA Recent Developments/Updates
Table 96. HANSOH PHARMLA Competitive Strengths & Weaknesses
Table 97. CHIATAI TIANQING Basic Information, Manufacturing Base and Competitors
Table 98. CHIATAI TIANQING Major Business
Table 99. CHIATAI TIANQING GLP-1 Weight Loss Drug Product and Services
Table 100. CHIATAI TIANQING GLP-1 Weight Loss Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. CHIATAI TIANQING Recent Developments/Updates
Table 102. CHIATAI TIANQING Competitive Strengths & Weaknesses
Table 103. Tonghua Dongbao Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 104. Tonghua Dongbao Pharmaceutical Major Business
Table 105. Tonghua Dongbao Pharmaceutical GLP-1 Weight Loss Drug Product and Services
Table 106. Tonghua Dongbao Pharmaceutical GLP-1 Weight Loss Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Tonghua Dongbao Pharmaceutical Recent Developments/Updates
Table 108. Huadong Medicine Basic Information, Manufacturing Base and Competitors
Table 109. Huadong Medicine Major Business
Table 110. Huadong Medicine GLP-1 Weight Loss Drug Product and Services
Table 111. Huadong Medicine GLP-1 Weight Loss Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 112. Global Key Players of GLP-1 Weight Loss Drug Upstream (Raw Materials)
Table 113. GLP-1 Weight Loss Drug Typical Customers
Table 114. GLP-1 Weight Loss Drug Typical Distributors
LIST OF FIGURE
Figure 1. GLP-1 Weight Loss Drug Picture
Figure 2. World GLP-1 Weight Loss Drug Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World GLP-1 Weight Loss Drug Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World GLP-1 Weight Loss Drug Production (2018-2029) & (K Units)
Figure 5. World GLP-1 Weight Loss Drug Average Price (2018-2029) & (US$/Unit)
Figure 6. World GLP-1 Weight Loss Drug Production Value Market Share by Region (2018-2029)
Figure 7. World GLP-1 Weight Loss Drug Production Market Share by Region (2018-2029)
Figure 8. North America GLP-1 Weight Loss Drug Production (2018-2029) & (K Units)
Figure 9. Europe GLP-1 Weight Loss Drug Production (2018-2029) & (K Units)
Figure 10. China GLP-1 Weight Loss Drug Production (2018-2029) & (K Units)
Figure 11. Japan GLP-1 Weight Loss Drug Production (2018-2029) & (K Units)
Figure 12. GLP-1 Weight Loss Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World GLP-1 Weight Loss Drug Consumption (2018-2029) & (K Units)
Figure 15. World GLP-1 Weight Loss Drug Consumption Market Share by Region (2018-2029)
Figure 16. United States GLP-1 Weight Loss Drug Consumption (2018-2029) & (K Units)
Figure 17. China GLP-1 Weight Loss Drug Consumption (2018-2029) & (K Units)
Figure 18. Europe GLP-1 Weight Loss Drug Consumption (2018-2029) & (K Units)
Figure 19. Japan GLP-1 Weight Loss Drug Consumption (2018-2029) & (K Units)
Figure 20. South Korea GLP-1 Weight Loss Drug Consumption (2018-2029) & (K Units)
Figure 21. ASEAN GLP-1 Weight Loss Drug Consumption (2018-2029) & (K Units)
Figure 22. India GLP-1 Weight Loss Drug Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of GLP-1 Weight Loss Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for GLP-1 Weight Loss Drug Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for GLP-1 Weight Loss Drug Markets in 2022
Figure 26. United States VS China: GLP-1 Weight Loss Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: GLP-1 Weight Loss Drug Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: GLP-1 Weight Loss Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers GLP-1 Weight Loss Drug Production Market Share 2022
Figure 30. China Based Manufacturers GLP-1 Weight Loss Drug Production Market Share 2022
Figure 31. Rest of World Based Manufacturers GLP-1 Weight Loss Drug Production Market Share 2022
Figure 32. World GLP-1 Weight Loss Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World GLP-1 Weight Loss Drug Production Value Market Share by Type in 2022
Figure 34. Injection
Figure 35. Oral
Figure 36. World GLP-1 Weight Loss Drug Production Market Share by Type (2018-2029)
Figure 37. World GLP-1 Weight Loss Drug Production Value Market Share by Type (2018-2029)
Figure 38. World GLP-1 Weight Loss Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World GLP-1 Weight Loss Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World GLP-1 Weight Loss Drug Production Value Market Share by Application in 2022
Figure 41. Online Pharmacy
Figure 42. Offline Pharmacy
Figure 43. World GLP-1 Weight Loss Drug Production Market Share by Application (2018-2029)
Figure 44. World GLP-1 Weight Loss Drug Production Value Market Share by Application (2018-2029)
Figure 45. World GLP-1 Weight Loss Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. GLP-1 Weight Loss Drug Industry Chain
Figure 47. GLP-1 Weight Loss Drug Procurement Model
Figure 48. GLP-1 Weight Loss Drug Sales Model
Figure 49. GLP-1 Weight Loss Drug Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
